Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness

Molecular and Cellular Proteomics

Volumn 13, Issue 7, 2014, Pages 1753-1768

  Liu, Yansheng ^a   Chen, Jing ^b   Sethi, Atul ^a   Li, Qing K ^b   Chen, Lijun ^b   Collins, Ben ^a   Gillet, Ludovic C J ^a   Wollscheid, Bernd ^a   Zhang, Hui ^b   Aebersold, Ruedi ^a,c  

^a ETH ZURICH   (Switzerland)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; CATHEPSIN F; CELL ADHESION MOLECULE; FIBRILLIN 1; GLYCOPROTEIN; INDUCIBLE T CELL COSTIMULATOR LIGAND; LAMININ; N ACYLETHANOLAMINE ACID AMIDASE; PROSTATE SPECIFIC ANTIGEN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE 7; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; AMIDASE; MEMBRANE PROTEIN; NAAA PROTEIN, HUMAN; PTK7 PROTEIN, HUMAN; TUMOR MARKER;

AMINO ACID SEQUENCE; ARTICLE; AUTOPSY; CANCER DIAGNOSIS; CANCER TISSUE; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; DATA ANALYSIS; GLEASON SCORE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; METASTASIS POTENTIAL; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEOMICS; SWATH MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TISSUE MICROARRAY; TUMOR AGGRESSIVENESS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN MICROARRAY; TUMOR INVASION;

AMIDOHYDROLASES; BIOMARKERS, TUMOR; CELL ADHESION MOLECULES; GENE EXPRESSION PROFILING; HUMANS; MALE; MASS SPECTROMETRY; MEMBRANE GLYCOPROTEINS; NEOPLASM INVASIVENESS; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84903692527     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M114.038273     Document Type: Article

References (90)

1. Siegel, R., Naishadham, D., and Jemal, A. (2013) Cancer statistics, 2013. CA 63, 11-30
2. Andriole, G. L., Crawford, E. D., Grubb, R. L., 3rd, Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., Weissfeld, J. L., Yokochi, L. A., O'Brien, B., Clapp, J. D., Rathmell, J. M., Riley, T. L., Hayes, R. B., Kramer, B. S., Izmirlian, G., Miller, A. B., Pinsky, P. F., Prorok, P. C., Gohagan, J. K., and Berg, C. D. (2009) Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 360, 1310-1319
3. Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., Ekman, P., De-Marzo, A. M., Tibshirani, R., Botstein, D., Brown, P. O., Brooks, J. D., and Pollack, J. R. (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 101, 811-816 (Pubitemid 38121040)
4. Sakr, W. A., Tefilli, M. V., Grignon, D. J., Banerjee, M., Dey, J., Gheiler, E. L., Tiguert, R., Powell, I. J., and Wood, D. P. (2000) Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival. Urology 56, 730-734
5. Pin, E., Fredolini, C., and Petricoin, E. F., 3rd (2013) The role of proteomics in prostate cancer research: biomarker discovery and validation. Clin. Biochem. 46, 524-538
6. Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C., Onofrio, R., Carter, S. L., Park, K., Habegger, L., Ambrogio, L., Fennell, T., Parkin, M., Saksena, G., Voet, D., Ramos, A. H., Pugh, T. J., Wilkinson, J., Fisher, S., Winckler, W., Mahan, S., Ardlie, K., Baldwin, J., Simons, J. W., Kitabayashi, N., MacDonald, T. Y., Kantoff, P. W., Chin, L., Gabriel, S. B., Gerstein, M. B., Golub, T. R., Meyerson, M., Tewari, A., Lander, E. S., Getz, G., Rubin, M. A., and Garraway, L. A. (2011) The genomic complexity of primary human prostate cancer. Nature 470, 214-220
7. Lin, P. C., Giannopoulou, E. G., Park, K., Mosquera, J. M., Sboner, A., Tewari, A. K., Garraway, L. A., Beltran, H., Rubin, M. A., and Elemento, O. (2013) Epigenomic alterations in localized and advanced prostate cancer. Neoplasia 15, 373-383
8. McDunn, J. E., Li, Z., Adam, K. P., Neri, B. P., Wolfert, R. L., Milburn, M. V., Lotan, Y., and Wheeler, T. M. (2013) Metabolomic signatures of aggressive prostate cancer. Prostate 73, 1547-1560
9. Soon, W. W., Hariharan, M., and Snyder, M. P. (2013) High-throughput sequencing for biology and medicine. Mol. Syst. Biol. 9, 640
10. Aebersold, R., Anderson, L., Caprioli, R., Druker, B., Hartwell, L., and Smith, R. (2005) Perspective: a program to improve protein biomarker discovery for cancer. J. Proteome Res. 4, 1104-1109 (Pubitemid 41208668)
11. Gutman, S., and Kessler, L. G. (2006) The US Food and Drug Administration perspective on cancer biomarker development. Nat. Rev. Cancer 6, 565-571 (Pubitemid 43980545)
12. Zhang, H., Yan, W., and Aebersold, R. (2004) Chemical probes and tandem mass spectrometry: a strategy for the quantitative analysis of proteomes and subproteomes. Curr. Opin. Chem. Biol. 8, 66-75 (Pubitemid 38201480)
13. Zhang, H., Loriaux, P., Eng, J., Campbell, D., Keller, A., Moss, P., Bonneau, R., Zhang, N., Zhou, Y., Wollscheid, B., Cooke, K., Yi, E. C., Lee, H., Peskind, E. R., Zhang, J., Smith, R. D., and Aebersold, R. (2006) UniPep, a database for human N-linked glycosites: a resource for biomarker discovery. Genome Biol. 7, R73
14. Zhang, H., and Chan, D. W. (2007) Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach. Cancer Epidemiol. Biomarkers Prev. 16, 1915-1917 (Pubitemid 47621162)
15. Roth, J. (2002) Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem. Rev. 102, 285-303
16. Schiess, R., Wollscheid, B., and Aebersold, R. (2009) Targeted proteomic strategy for clinical biomarker discovery. Mol. Oncol. 3, 33-44
17. Zhang, H., Liu, A. Y., Loriaux, P., Wollscheid, B., Zhou, Y., Watts, J. D., and Aebersold, R. (2007) Mass spectrometric detection of tissue proteins in plasma. Mol. Cell. Proteomics 6, 64-71 (Pubitemid 46152692)
18. Zhang, H., Li, X. J., Martin, D. B., and Aebersold, R. (2003) Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21, 660-666 (Pubitemid 36638093)
19. Tian, Y., Zhou, Y., Elliott, S., Aebersold, R., and Zhang, H. (2007) Solidphase extraction of N-linked glycopeptides. Nat. Protoc. 2, 334-339
20. Chen, J., Xi, J., Tian, Y., Bova, G. S., and Zhang, H. (2013) Identification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens. Proteomics 13, 2268-2277
21. Zhao, J., Simeone, D. M., Heidt, D., Anderson, M. A., and Lubman, D. M. (2006) Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J. Proteome Res. 5, 1792-1802 (Pubitemid 44036154)
22. Tian, Y., Bova, G. S., and Zhang, H. (2011) Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer. Anal. Chem. 83, 7013-7019
23. Cima, I., Schiess, R., Wild, P., Kaelin, M., Schuffler, P., Lange, V., Picotti, P., Ossola, R., Templeton, A., Schubert, O., Fuchs, T., Leippold, T., Wyler, S., Zehetner, J., Jochum, W., Buhmann, J., Cerny, T., Moch, H., Gillessen, S., Aebersold, R., and Krek, W. (2011) Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 108, 3342-3347
24. Chen, R., Tan, Y., Wang, M., Wang, F., Yao, Z., Dong, L., Ye, M., Wang, H., and Zou, H. (2011) Development of glycoprotein capture-based labelfree method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma. Mol. Cell. Proteomics 10, M110.006445
25. Zeng, X., Hood, B. L., Sun, M., Conrads, T. P., Day, R. S., Weissfeld, J. L., Siegfried, J. M., and Bigbee, W. L. (2010) Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. J. Proteome Res. 9, 6440-6449
26. Gillet, L. C., Navarro, P., Tate, S., Rost, H., Selevsek, N., Reiter, L., Bonner, R., and Aebersold, R. (2012) Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 11, O111.016717
27. Liu, Y., Huttenhain, R., Collins, B., and Aebersold, R. (2013) Mass spectrometric protein maps for biomarker discovery and clinical research. Expert Rev. Mol. Diagn. 13, 811-825
28. Liu, Y., Huttenhain, R., Surinova, S., Gillet, L. C., Mouritsen, J., Brunner, R., Navarro, P., and Aebersold, R. (2013) Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS. Proteomics 13, 1247-1256
29. Collins, B. C., Gillet, L. C., Rosenberger, G., Rost, H. L., Vichalkovski, A., Gstaiger, M., and Aebersold, R. (2013) Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system. Nat. Methods 10, 1246-1253
30. Escher, C., Reiter, L., MacLean, B., Ossola, R., Herzog, F., Chilton, J., MacCoss, M. J., and Rinner, O. (2012) Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 12, 1111-1121
31. Huttenhain, R., Surinova, S., Ossola, R., Sun, Z., Campbell, D., Cerciello, F., Schiess, R., Bausch-Fluck, D., Rosenberger, G., Chen, J., Rinner, O., Kusebauch, U., Hajduch, M., Moritz, R. L., Wollscheid, B., and Aebersold, R. (2013) N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications. Mol. Cell. Proteomics 12, 1005-1016
32. Frank, R. (2002) The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J. Immunol. Methods 267, 13-26
33. Elias, J. E., and Gygi, S. P. (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207-214 (Pubitemid 46358868)
34. Yates, J. R., 3rd, Eng, J. K., McCormack, A. L., and Schieltz, D. (1995) Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal. Chem. 67, 1426-1436
35. Keller, A., Eng, J., Zhang, N., Li, X. J., and Aebersold, R. (2005) A uniform proteomics MS/MS analysis platform utilizing open XML file formats. Mol. Syst. Biol. 1, 2005.0017
36. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392 (Pubitemid 35215372)
37. Lam, H., Deutsch, E. W., Eddes, J. S., Eng, J. K., King, N., Stein, S. E., and Aebersold, R. (2007) Development and validation of a spectral library searching method for peptide identification from MS/MS. Proteomics 7, 655-667 (Pubitemid 46453760)
38. Kessner, D., Chambers, M., Burke, R., Agus, D., and Mallick, P. (2008) ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 24, 2534-2536
39. Rost, H. L., Rosenberger, G., Navarro, P., Gillet, L., Miladinovic, S. M., Schubert, O. T., Wolski, W., Collins, B. C., Malmstrom, J., Malmstrom, L., and Aebersold, R. (2014) OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data. Nat. Biotechnol. 32, 219-223
40. Reiter, L., Rinner, O., Picotti, P., Huttenhain, R., Beck, M., Brusniak, M. Y., Hengartner, M. O., and Aebersold, R. (2011) mProphet: automated data processing and statistical validation for large-scale SRM experiments. Nat. Methods 8, 430-435
41. Weisser, H., Nahnsen, S., Grossmann, J., Nilse, L., Quandt, A., Brauer, H., Sturm, M., Kenar, E., Kohlbacher, O., Aebersold, R., and Malmstrom, L. (2013) An automated pipeline for high-throughput label-free quantitative proteomics. J. Proteome Res. 12, 1628-1644
42. Quackenbush, J. (2002) Microarray data normalization and transformation. Nat. Genet. 32 Suppl, 496-501
43. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95, 14863-14868 (Pubitemid 29003722)
44. Juan, H. F., and Huang, H. C. (2007) Bioinformatics: microarray data clustering and functional classification. Methods Mol. Biol. 382, 405-416
45. Ludwig, C., Claassen, M., Schmidt, A., and Aebersold, R. (2012) Estimation of absolute protein quantities of unlabeled samples by selected reaction monitoring mass spectrometry. Mol. Cell. Proteomics 11, M111.013987
46. Morrissey, E. R., and Diaz-Uriarte, R. (2009) Pomelo II: finding differentially expressed genes. Nucleic Acids Res. 37, W581-W586
47. Maere, S., Heymans, K., and Kuiper, M. (2005) BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21, 3448-3449 (Pubitemid 41222459)
48. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., and Ideker, T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 (Pubitemid 37428274)
49. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
50. Petersen, T. N., Brunak, S., von Heijne, G., and Nielsen, H. (2011) SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Methods 8, 785-786
51. Krogh, A., Larsson, B., von Heijne, G., and Sonnhammer, E. L. (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305, 567-580 (Pubitemid 33032862)
52. Omasits, U., Ahrens, C. H., Muller, S., and Wollscheid, B. (2013) Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics 30, 884-886
53. Jeong, S. K., Na, K., Kim, K. Y., Kim, H., and Paik, Y. K. (2012) Panel-Composer: a web-based panel construction tool for multivariate analysis of disease biomarker candidates. J. Proteome Res. 11, 6277-6281
54. Wu, G., Feng, X., and Stein, L. (2010) A human functional protein interaction network and its application to cancer data analysis. Genome Biol. 11, R53
55. Haw, R., Hermjakob, H., D'Eustachio, P., and Stein, L. (2011) Reactome pathway analysis to enrich biological discovery in proteomics data sets. Proteomics 11, 3598-3613
56. Kumar, A., White, T. A., MacKenzie, A. P., Clegg, N., Lee, C., Dumpit, R. F., Coleman, I., Ng, S. B., Salipante, S. J., Rieder, M. J., Nickerson, D. A., Corey, E., Lange, P. H., Morrissey, C., Vessella, R. L., Nelson, P. S., and Shendure, J. (2011) Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc. Natl. Acad. Sci. U.S.A. 108, 17087-17092
57. Weischenfeldt, J., Simon, R., Feuerbach, L., Schlangen, K., Weichenhan, D., Minner, S., Wuttig, D., Warnatz, H. J., Stehr, H., Rausch, T., Jager, N., Gu, L., Bogatyrova, O., Stutz, A. M., Claus, R., Eils, J., Eils, R., Gerhauser, C., Huang, P. H., Hutter, B., Kabbe, R., Lawerenz, C., Radomski, S., Bartholomae, C. C., Falth, M., Gade, S., Schmidt, M., Amschler, N., Hass, T., Galal, R., Gjoni, J., Kuner, R., Baer, C., Masser, S., von Kalle, C., Zichner, T., Benes, V., Raeder, B., Mader, M., Amstislavskiy, V., Avci, M., Lehrach, H., Parkhomchuk, D., Sultan, M., Burkhardt, L., Graefen, M., Huland, H., Kluth, M., Krohn, A., Sirma, H., Stumm, L., Steurer, S., Grupp, K., Sultmann, H., Sauter, G., Plass, C., Brors, B., Yaspo, M. L., Korbel, J. O., and Schlomm, T. (2013) Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell 23, 159-170
58. Kannan, K., Wang, L., Wang, J., Ittmann, M. M., Li, W., and Yen, L. (2011) Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing. Proc. Natl. Acad. Sci. U.S.A. 108, 9172-9177
59. Barbieri, C. E., Baca, S. C., Lawrence, M. S., Demichelis, F., Blattner, M., Theurillat, J. P., White, T. A., Stojanov, P., Van Allen, E., Stransky, N., Nickerson, E., Chae, S. S., Boysen, G., Auclair, D., Onofrio, R. C., Park, K., Kitabayashi, N., MacDonald, T. Y., Sheikh, K., Vuong, T., Guiducci, C., Cibulskis, K., Sivachenko, A., Carter, S. L., Saksena, G., Voet, D., Hussain, W. M., Ramos, A. H., Winckler, W., Redman, M. C., Ardlie, K., Tewari, A. K., Mosquera, J. M., Rupp, N., Wild, P. J., Moch, H., Morrissey, C., Nelson, P. S., Kantoff, P. W., Gabriel, S. B., Golub, T. R., Meyerson, M., Lander, E. S., Getz, G., Rubin, M. A., and Garraway, L. A. (2012) Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689
60. Grasso, C. S., Wu, Y. M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., Asangani, I. A., Ateeq, B., Chun, S. Y., Siddiqui, J., Sam, L., Anstett, M., Mehra, R., Prensner, J. R., Palanisamy, N., Ryslik, G. A., Vandin, F., Raphael, B. J., Kunju, L. P., Rhodes, D. R., Pienta, K. J., Chinnaiyan, A. M., and Tomlins, S. A. (2012) The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239-243
61. Milo, R., Kashtan, N., Itzkovitz, S., Newman, M. E. J., and Alon, U. (2003) On the uniform generation of random graphs with prescribed degree sequences. Cond. Matter 2, 1-4
62. Liu, Y., Luo, X., Hu, H., Wang, R., Sun, Y., Zeng, R., and Chen, H. (2012) Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer. PLoS One 7, e51748
63. Liu, Y., Li, C., Xing, Z., Yuan, X., Wu, Y., Xu, M., Tu, K., Li, Q., Wu, C., Zhao, M., and Zeng, R. (2010) Proteomic mining in the dysplastic liver of WHV/c-myc mice - insights and indicators for early hepatocarcinogenesis. FEBS J. 277, 4039-4053
64. Vizcaino, J. A., Cote, R. G., Csordas, A., Dianes, J. A., Fabregat, A., Foster, J. M., Griss, J., Alpi, E., Birim, M., Contell, J., O'Kelly, G., Schoenegger, A., Ovelleiro, D., Perez-Riverol, Y., Reisinger, F., Rios, D., Wang, R., and Hermjakob, H. (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-D1069
65. Lambert, J. P., Ivosev, G., Couzens, A. L., Larsen, B., Taipale, M., Lin, Z. Y., Zhong, Q., Lindquist, S., Vidal, M., Aebersold, R., Pawson, T., Bonner, R., Tate, S., and Gingras, A. C. (2013) Mapping differential interactomes by affinity purification coupled with data-independent mass spectrometry acquisition. Nat. Methods 10, 1239-1245
66. Domon, B., and Aebersold, R. (2010) Options and considerations when selecting a quantitative proteomics strategy. Nat. Biotechnol. 28, 710-721
67. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., Wernerus, H., Bjorling, L., and Ponten, F. (2010) Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250
68. Prensner, J. R., Rubin, M. A., Wei, J. T., and Chinnaiyan, A. M. (2012) Beyond PSA: the next generation of prostate cancer biomarkers. Sci. Translat. Med. 4, 127rv123
69. Robey, E. L., Schellhammer, P. F., Wright, G. L., Jr., and el-Mahdi, A. M. (1985) Cancer serum index and prostatic acid phosphatase for detection of progressive prostatic cancer. J. Urol. 134, 787-790 (Pubitemid 16247706)
70. Caccia, D., Zanetti Domingues, L., Micciche, F., De Bortoli, M., Carniti, C., Mondellini, P., and Bongarzone, I. (2011) Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways. J. Proteome Res. 10, 4196-4207
71. Luo, X., Liu, Y., Wang, R., Hu, H., Zeng, R., and Chen, H. (2011) A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer. J. Proteomics 74, 528-538
72. Kalin, M., Cima, I., Schiess, R., Fankhauser, N., Powles, T., Wild, P., Templeton, A., Cerny, T., Aebersold, R., Krek, W., and Gillessen, S. (2011) Novel prognostic markers in the serum of patients with castrationresistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome. Eur. Urol. 60, 1235-1243
73. Farrah, T., Deutsch, E. W., Omenn, G. S., Campbell, D. S., Sun, Z., Bletz, J. A., Mallick, P., Katz, J. E., Malmstrom, J., Ossola, R., Watts, J. D., Lin, B., Zhang, H., Moritz, R. L., and Aebersold, R. (2011) A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell. Proteomics 10, M110.006353
74. Zhang, H., Yi, E. C., Li, X. J., Mallick, P., Kelly-Spratt, K. S., Masselon, C. D., Camp, D. G., 2nd, Smith, R. D., Kemp, C. J., and Aebersold, R. (2005) High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol. Cell. Proteomics 4, 144-155 (Pubitemid 40361177)
75. Toprak, U. H., Gillet, L. C., Maiolica, A., Navarro, P., Leitner, A., and Aebersold, R. (2014) Conserved peptide fragmentation as a benchmarking tool for mass spectrometers and a discriminating feature for targeted proteomics. Mol. Cell. Proteomics doi:10.1074/mcp.O113.036475
76. Cohen, M. B., Griebling, T. L., Ahaghotu, C. A., Rokhlin, O. W., and Ross, J. S. (1997) Cellular adhesion molecules in urologic malignancies. Am. J. Clin. Pathol. 107, 56-63 (Pubitemid 27104637)
77. Goel, H. L., Li, J., Kogan, S., and Languino, L. R. (2008) Integrins in prostate cancer progression. Endocrine Relat. Cancer 15, 657-664
78. Jin, S., and White, E. (2007) Role of autophagy in cancer: management of metabolic stress. Autophagy 3, 28-31 (Pubitemid 46100707)
79. Wisniewski, J. R., Ostasiewicz, P., Dus, K., Zielinska, D. F., Gnad, F., and Mann, M. (2012) Extensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma. Mol. Syst. Biol. 8, 611
80. Chen, J., Shah, P., and Zhang, H. (2013) Solid phase extraction of N-linked glycopeptides using hydrazide tip. Anal. Chem. 85, 10670-10674
81. Tsuboi, K., Sun, Y. X., Okamoto, Y., Araki, N., Tonai, T., and Ueda, N. (2005) Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J. Biol. Chem. 280, 11082-11092 (Pubitemid 40418412)
82. Sun, Y. X., Tsuboi, K., Zhao, L. Y., Okamoto, Y., Lambert, D. M., and Ueda, N. (2005) Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Biochim. Biophys. Acta 1736, 211-220 (Pubitemid 41423705)
83. Wang, J., Zhao, L. Y., Uyama, T., Tsuboi, K., Wu, X. X., Kakehi, Y., and Ueda, N. (2008) Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells. J. Biochem. 144, 685-690
84. Shangguan, D., Cao, Z., Meng, L., Mallikaratchy, P., Sefah, K., Wang, H., Li, Y., and Tan, W. (2008) Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J. Proteome Res. 7, 2133-2139
85. Muller-Tidow, C., Schwable, J., Steffen, B., Tidow, N., Brandt, B., Becker, K., Schulze-Bahr, E., Halfter, H., Vogt, U., Metzger, R., Schneider, P. M., Buchner, T., Brandts, C., Berdel, W. E., and Serve, H. (2004) Highthroughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets. Clin. Cancer Res. 10, 1241-1249 (Pubitemid 38365213)
86. Shin, W. S., Kwon, J., Lee, H. W., Kang, M. C., Na, H. W., Lee, S. T., and Park, J. H. (2013) Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma. Cancer Sci. 104, 1120-1126
87. Shin, W. S., Maeng, Y. S., Jung, J. W., Min, J. K., Kwon, Y. G., and Lee, S. T. (2008) Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis. Biochem. Biophys. Res. Commun. 371, 793-798
88. Lin, Y., Zhang, L. H., Wang, X. H., Xing, X. F., Cheng, X. J., Dong, B., Hu, Y., Du, H., Li, Y. A., Zhu, Y. B., Ding, N., Du, Y. X., Li, J. Y., and Ji, J. F. (2012) PTK7 as a novel marker for favorable gastric cancer patient survival. J. Surg. Oncol. 106, 880-886
89. Endoh, H., Tomida, S., Yatabe, Y., Konishi, H., Osada, H., Tajima, K., Kuwano, H., Takahashi, T., and Mitsudomi, T. (2004) Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J. Clin. Oncol. 22, 811-819 (Pubitemid 41103592)
90. Ataseven, B., Angerer, R., Kates, R., Gunesch, A., Knyazev, P., Hogel, B., Becker, C., Eiermann, W., and Harbeck, N. (2013) PTK7 expression in triple-negative breast cancer. Anticancer Res. 33, 3759-3763